365 related articles for article (PubMed ID: 32266248)
1. Hydrogel Biomaterials for Application in Ocular Drug Delivery.
Lynch CR; Kondiah PPD; Choonara YE; du Toit LC; Ally N; Pillay V
Front Bioeng Biotechnol; 2020; 8():228. PubMed ID: 32266248
[TBL] [Abstract][Full Text] [Related]
2. Hydrogel-based ocular drug delivery systems for hydrophobic drugs.
Torres-Luna C; Fan X; Domszy R; Hu N; Wang NS; Yang A
Eur J Pharm Sci; 2020 Nov; 154():105503. PubMed ID: 32745587
[TBL] [Abstract][Full Text] [Related]
3. Interpenetrating polymeric network (IPNs) in ophthalmic drug delivery: Breaking the barriers.
Rathod S
Int Ophthalmol; 2023 Mar; 43(3):1063-1074. PubMed ID: 36053474
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal Injectable Hydrogels for Sustained Drug Delivery in Glaucoma Treatment and Therapy.
Akulo KA; Adali T; Moyo MTG; Bodamyali T
Polymers (Basel); 2022 Jun; 14(12):. PubMed ID: 35745935
[TBL] [Abstract][Full Text] [Related]
5. Advanced Hydrogels Based Drug Delivery Systems for Ophthalmic Delivery.
Gorantla S; Waghule T; Rapalli VK; Singh PP; Dubey SK; Saha RN; Singhvi G
Recent Pat Drug Deliv Formul; 2019; 13(4):291-300. PubMed ID: 31912771
[TBL] [Abstract][Full Text] [Related]
6. Considerations for Polymers Used in Ocular Drug Delivery.
Allyn MM; Luo RH; Hellwarth EB; Swindle-Reilly KE
Front Med (Lausanne); 2021; 8():787644. PubMed ID: 35155469
[TBL] [Abstract][Full Text] [Related]
7. Advances and limitations of drug delivery systems formulated as eye drops.
Jumelle C; Gholizadeh S; Annabi N; Dana R
J Control Release; 2020 May; 321():1-22. PubMed ID: 32027938
[TBL] [Abstract][Full Text] [Related]
8. Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System.
Akhter MH; Ahmad I; Alshahrani MY; Al-Harbi AI; Khalilullah H; Afzal O; Altamimi ASA; Najib Ullah SNM; Ojha A; Karim S
Gels; 2022 Jan; 8(2):. PubMed ID: 35200463
[TBL] [Abstract][Full Text] [Related]
9. A stimulus-responsive, in situ-forming, nanoparticle-laden hydrogel for ocular drug delivery.
Kabiri M; Kamal SH; Pawar SV; Roy PR; Derakhshandeh M; Kumar U; Hatzikiriakos SG; Hossain S; Yadav VG
Drug Deliv Transl Res; 2018 Jun; 8(3):484-495. PubMed ID: 29508159
[TBL] [Abstract][Full Text] [Related]
10. Stimulus-Responsive Hydrogel for Ophthalmic Drug Delivery.
Lin D; Lei L; Shi S; Li X
Macromol Biosci; 2019 Jun; 19(6):e1900001. PubMed ID: 31026123
[TBL] [Abstract][Full Text] [Related]
11. Potential of Stimuli-Responsive In Situ Gel System for Sustained Ocular Drug Delivery: Recent Progress and Contemporary Research.
Pandey M; Choudhury H; Binti Abd Aziz A; Bhattamisra SK; Gorain B; Su JST; Tan CL; Chin WY; Yip KY
Polymers (Basel); 2021 Apr; 13(8):. PubMed ID: 33923900
[TBL] [Abstract][Full Text] [Related]
12. Ophthalmic gels: Past, present and future.
Al-Kinani AA; Zidan G; Elsaid N; Seyfoddin A; Alani AWG; Alany RG
Adv Drug Deliv Rev; 2018 Feb; 126():113-126. PubMed ID: 29288733
[TBL] [Abstract][Full Text] [Related]
13. Review of Applications and Future Prospects of Stimuli-Responsive Hydrogel Based on Thermo-Responsive Biopolymers in Drug Delivery Systems.
Chatterjee S; Hui PC
Polymers (Basel); 2021 Jun; 13(13):. PubMed ID: 34202828
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.
Tsung TH; Tsai YC; Lee HP; Chen YH; Lu DW
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629157
[TBL] [Abstract][Full Text] [Related]
15. A biomimetic peptide-drug supramolecular hydrogel as eyedrops enables controlled release of ophthalmic drugs.
Pan M; Ren Z; Ma X; Chen L; Lv G; Liu X; Li S; Li X; Wang J
Acta Biomater; 2023 Sep; 167():195-204. PubMed ID: 37392932
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, classification and properties of hydrogels: their applications in drug delivery and agriculture.
Khan F; Atif M; Haseen M; Kamal S; Khan MS; Shahid S; Nami SAA
J Mater Chem B; 2022 Jan; 10(2):170-203. PubMed ID: 34889937
[TBL] [Abstract][Full Text] [Related]
17. Biopolymers in Mucoadhesive Eye Drops for Treatment of Dry Eye and Allergic Conditions: Application and Perspectives.
Račić A; Krajišnik D
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839790
[TBL] [Abstract][Full Text] [Related]
18. Polysaccharide as renewable responsive biopolymer for in situ gel in the delivery of drug through ocular route.
Chowhan A; Giri TK
Int J Biol Macromol; 2020 May; 150():559-572. PubMed ID: 32057864
[TBL] [Abstract][Full Text] [Related]
19. Injectable drug depot engineered to release multiple ophthalmic therapeutic agents with precise time profiles for postoperative treatment following ocular surgery.
Mohammadi M; Patel K; Alaie SP; Shmueli RB; Besirli CG; Larson RG; Green JJ
Acta Biomater; 2018 Jun; 73():90-102. PubMed ID: 29684622
[TBL] [Abstract][Full Text] [Related]
20. Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.
Tashakori-Sabzevar F; Mohajeri SA
Drug Dev Ind Pharm; 2015 May; 41(5):703-13. PubMed ID: 25113431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
